Community outreach may boost PrEP interest in High-Risk groups
NCT ID NCT05949814
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested how acceptable HIV pre-exposure prophylaxis (PrEP) is among men who have sex with men and transgender individuals who agreed to HIV/STI testing through a community-based outreach program, both online and in person. Researchers recruited 209 participants via a geolocation app or community venues. The goal was to see how many people who were eligible for PrEP actually accepted it one month later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help design better community-based programs to increase PrEP uptake and reduce HIV transmission among high-risk groups.
What could go wrong
This is a completed observational study with 209 participants, so results may not apply to broader populations or other settings. It measures acceptability, not actual PrEP effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Le SPOT
Paris, Île-de-France Region, 75011, France